Fierce Biotech32 分钟
MacroGenics pulls plug on vobra duo ADC after seeing phase 2 prostate cancer data
MGC026, which is a TOP1i-based ADC, is undergoing a phase 1 dose-escalation study in patients with advanced solid tumors. The ...
The Star51 分钟
Sabina Chege in push to have recruiting agencies re-vetted
The bill, the MP said, will protect Kenyans who are duped by the agencies and left stranded in foreign countries.